WO2014006045A1 - Psoralen derivatives for preventing or treating ...,https://www.google.com/patents/WO2014006045A1?cl=ja
WO2007052561A1 - Method for prevention of myocardial ...,https://www.google.com/patents/WO2007052561A1?cl=en
WO2015162161A1 - Lncrnas for therapy and diagnosis of cardiac ...,https://www.google.com/patents/WO2015162161A1?cl=zh
US20170231982A1 - Methods and compositions for prevention and ...,http://www.google.com/patents/US20170231982?utm_source=gb-gplus-sharePatent
EP3134526A1 - Lncrnas for therapy and diagnosis of cardiac ...,https://www.google.com/patents/EP3134526A1?cl=en
WO2005107756A1 - A method for the treatment or prevention of ...,https://www.google.com/patents/WO2005107756A1?cl=en11
Process for the treatment of benign prostatic hypertrophy,https://www.google.com/patents/US3639615
US5610136A - Method for treatment of benign prostatic hypertrophy ...,https://www.google.com/patents/US5610136
EP0911034A1 - Medicinal compositions for treating cardiac ...,https://www.google.com/patents/EP0911034A1?cl=fi
US6221618B1 - Retinoid suppression of ventricular muscle cell ...,https://google.com/patents/US6221618
